Brief: Evolus Announces Submission Of Premarket Approval Application To The U.S. Food And Drug Administration For First Two Evolysse™ Dermal Filler Products
24/06/2024 15:18
June 24 (Reuters) - Evolus Inc EOLS.O :
* EVOLUS ANNOUNCES SUBMISSION OF PREMARKET APPROVAL
APPLICATION TO
THE U.S. FOOD AND DRUG ADMINISTRATION FOR FIRST TWO EVOLYSSE™
DERMAL FILLER PRODUCTS
Source text for Eikon: ID:nBw6XzF0za
Further company coverage: EOLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe